Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Mifepristone Ancillary Trial Costs Are Being Covered By Seattle-Area Insurers

Executive Summary

Cost of supportive care in the Abortion Rights Mobilization investigational studies of mifepristone (RU-486) are being paid by insurers in Washington state, Deborah Oyer, MD, Aurora Medical Services (Seattle), said at a press briefing Oct. 4.

You may also be interested in...

Mifeprex Label Allows Use By Physicians Not Trained In Surgical Abortion

The Population Council and Danco Labs will conduct a postmarketing safety study to compare outcomes for Mifeprex (mifepristone) patients treated by physicians trained in surgical abortion versus those treated by physicians not trained in abortion.

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts